| Application no. and date | 18173134.0 (espacenet) (Federated) (European Patent Register), 20160816 | | Patent/reg. no. and date | DK/EP 3385395, 20200129 | | Publication date | 20181010 | | Priority no. and date | US 201562206194 P, 20150817, US 201562218927 P, 20150915, US 201562241019 P, 20151013, US 201662310582 P, 20160318, US 201662372662 P, 20160809 | | EP pub. no. and date |
EP 3385395 20181010 | | Effective date | | | Applicant/owner | Kura Oncology, Inc., 12730 High Bluff Drive, Suite 400
San Diego, CA 92130 , US | | Applicant ref. no. | P72578DK01 | | Inventor | GUALBERTO, Antonio, 8 Larch Road
Acton, MA 01720, US,
SCHOLZ, Catherine Rose, 8 James Millen Road
North Reading,MA 01864, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | C12Q 1/68 (2018.01) | | Title | FREMGANGSMÅDER TIL BEHANDLING AF CANCERPATIENTER MED FARNESYLTRANSFERASE-INHIBITORER | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
